IJCM  Vol.5 No.5 , March 2014
Long-Term Prognostic Factors in Patients with Significant Left Main Coronary Artery Disease
ABSTRACT

Introduction and Objectives: The natural history of patients with left main coronary artery disease (LMCAD) is largely unknown. Our objective was to analyse the predictors of long-term mortality in these patients, both those that have had surgery and those that have not undergone surgery for various reasons, in a cohort treated at a university hospital. Methods: The study included patients with significant LMCAD diagnosed through consecutive coronary angiograms from 2001 to 2009. Clinical variables, the reasons for cardiac catheterisation, therapeutic decisions and clinical evolution in long-term follow-up were analysed. Results: Of the 163 patients included in the analysis, a total of 109 (66.9%) underwent revascularisation, while the remaining 54 (33.1%) received other medical treatment. We analysed the clinical events that took place with a mean follow-up period of 54 months (IQR: 25-95). The non-revascularised group had a lower survival rate than the revascularised group in unadjusted analysis (logrank test 0.005). Age (OR 1.04, CI 1.02-1.07, p = 0.001), ventricular dysfunction (OR 2.87, CI95% 1.71-4.81, p < 0.0001), clinical instability (OR 2.11, CI95% 1.08 to 4.13, p = 0.028) and above 70% severity of LMCAD (OR 1.78, CI 1.09 to 2.91, p = 0.021) were independent predictors of mortality for the entire cohort, but revascularisation was not. Conclusions: Revascularisation is associated with improved survival in patients with LMCAD, but only age, ventricular dysfunction, clinical instability and the severity of the lesion are independent predictors of long-term mortality in the unselected population.


Cite this paper
Camprubí, M. , Castro, R. , Mohandes, M. , Guarinos, J. , Garcia-Bermúdez, M. and Bardají, A. (2014) Long-Term Prognostic Factors in Patients with Significant Left Main Coronary Artery Disease. International Journal of Clinical Medicine, 5, 188-196. doi: 10.4236/ijcm.2014.55032.
References
[1]   Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC), The European Association for Cardio-Thoracic Surgery (EACTS) and European Association for Percutaneous Cardiovascular Interventions (EAPCI) (2010) Guidelines on Myocardial Revascularization. European Heart Journal, 31, 2501-2555.
http://dx.doi.org/10.1093/eurheartj/ehq277

[2]   Hillis, L.D., et al. (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 124, 2610-2642. http://dx.doi.org/10.1161/CIR.0b013e31823b5fee

[3]   Chakravarty, T., Buch, M.H., Naik, H., White, A.J., Doctor, N., Schapira, J., et al. (2011) Predictive Accuracy of SYNTAX Score for Predicting Long-Term Outcomes of Unprotected Left Main Coronary Artery Revascularization. American Journal of Cardiology, 107, 360-366. http://dx.doi.org/10.1016/j.amjcard.2010.09.029

[4]   Kim, Y.H., Park, D.W., Kim, W.J., Lee, J.Y., Yun, S.C., Kang, S.J., Lee, S.W., Lee, C.W., Park, S.W. and Park, S.J. (2010) Validation of SYNTAX (Synergy between PCI with TAXUS and Cardiac Surgery) Score for Prediction of Outcomes after Unprotected Left Main Coronary Revascularization. JACC Cardiovascular Interventions, 3, 612-623.
http://dx.doi.org/10.1016/j.jcin.2010.04.004

[5]   Serruys, P. and Garg, S. (2009) Percutaneous Coronary Interventions for All Patients with Complex Coronary Artery Disease: Triple Vessel Disease or Left Main Coronary Artery Disease. Yes? No? Don’t Know? Revista Española de Cardiología, 62, 719-725. http://dx.doi.org/10.1016/S0300-8932(09)71683-5

[6]   De Lorenzo, A., Tura, B., Bassan, F., Pittella, F. and Rocha, A.S. (2011) Outcomes of Patients with Left Main Coronary Artery Disease Undergoing Medical or Surgical Treatment: A Propensity-Matched Analysis. Coronary Artery Disease, 22, 585-589. http://dx.doi.org/10.1097/MCA.0b013e32834c7501

[7]   Gziut, A., Gil, R. and Kulawik, T. (2010) Comparative Analysis of Conservative, Percutaneous, and Surgical Treatment Outcomes in Patients with Significant Stenosis of the Left Main Coronary Artery during Five-Year Follow-Up. Kardiologia Polska, 68, 381-390.

[8]   Gan, H.L., Zhang, J.Q., Bo, P., Wang, S.X. and Lu, C.S. (2010) Statins Decrease Adverse Outcomes in Coronary Artery Bypass for Extensive Coronary Artery Disease As Well As Left Main Coronary Stenosis. Cardiovascular Therapeutics, 28, 70-79. http://dx.doi.org/10.1111/j.1755-5922.2009.00098.x

[9]   Martí, V., Planas, F., Cotes, C., García, J., Guiteras, P., López, L. and Augé, J.M. (2004) Resultados Inmediatos y a Largo Plazo de la Angioplastia con stent del Tronco Común. Revista Española de Cardiología, 57, 1029-1034.
http://dx.doi.org/10.1016/S0300-8932(04)77238-3

[10]   Gomez-Hospital, J.A., Gomez-Lara, J., Rondan, J., Homs, S., Lozano Martinez-Luengas, I., Ferreiro, J.L., Roura, G., Maristany, J., Teruel, L., Carro, A., Avanzas, P., Jara, P., Esplugas, E., Moris, Z. and Cequier, A. (2012) Seguimiento a Largo Plazo tras el Tratamiento Percutáneo del Tronco Coronario Izquierdo no Protegido en Pacientes de Alto Riesgo no Aptos para Cirugía de Revascularización. Revista Española de Cardiología, 65, 530-537.
http://dx.doi.org/10.1016/j.recesp.2011.12.020

[11]   López-Palop, R., Pinar, E., Saura, D., Pérez-Lorente, F., Lozano, I., Teruel, F., et al. (2004) Resultados a Corto y Medio Plazo del Intervencionismo Coronario Percutáneo Sobre el Tronco Coronario Común Izquierdo no Protegido en Pacientes Malos Candidatos para Revascularización Quirúrgica. Revista Española de Cardiología, 57, 1035-1044.
http://dx.doi.org/10.1016/S0300-8932(04)77239-5

[12]   Ielasi, A., Latib, A., Chieffo, A., Takagi, K., Mussardo, M., Davidavicius, G., et al. (2013) Very Long-Term Outcomes Following Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis: A Single Center Experience. Revista Española de Cardiología, 66, 24-33. http://dx.doi.org/10.1016/j.recesp.2012.06.026

[13]   Yusuf, S., Zucker, D., Peduzzi, P., Fisher, L.D., Takaro, T., Kennedy, J.W., et al. (1994) Effect of Coronary Artery Bypass Graft Surgery on Survival: Overview of 10-Year Results from Randomised Trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet, 344, 563-570. http://dx.doi.org/10.1016/S0140-6736(94)91963-1

[14]   Serruys, P.W., Morice, M.C., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., et al. (2009) Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine, 360, 961-972. http://dx.doi.org/10.1056/NEJMoa0804626

[15]   Taylor, H.A., Deumite, N.J., Chaitman, B.R., Davis, K.B., Killip, T. and Rogers, W.J. (1989) Asymptomatic Left Main Coronary Artery Disease in the Coronary Artery Surgery Study (CASS) Registry. Circulation, 79, 1171-1179.
http://dx.doi.org/10.1161/01.CIR.79.6.1171

[16]   Amanullah, A.M., Heo, J., Acio, E., Narula, J. and Iskandrian, A.E. (1999) Predictors of Outcome of Medically Treated Patients with Left Main/Three-Vessel Coronary Artery Disease by Coronary Angiography. American Journal of Cardiology, 83, 445-448. http://dx.doi.org/10.1016/S0002-9149(98)00883-2

[17]   Takaro, T., Peduzzi, P., Detre, K.M., Hultgren, H.N., Murphy, M.L., van der Bel-Kahn, J., et al. (1982) Survival in Subgroups of Patients with Left Main Coronary Artery Disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation, 66, 14-22. http://dx.doi.org/10.1161/01.CIR.66.1.14

[18]   Caracciolo, E.A., Davis, K.B., Sopko, G., Kaiser, G.C., Corley, S.D., Schaff, H., et al. (1995) Comparison of Surgical and Medical Group Survival in Patients with Left Main Coronary Artery Disease. Long-Term CASS Experience. Circulation, 91, 2325-2334. http://dx.doi.org/10.1161/01.CIR.91.9.2325

[19]   Gyenes, G., Shrive, F.M., Graham, M.M., Ghali, W.A. and Knudtson, M.L. (2006) APPROACH Investigators. The Prognostic Importance of Nonsignificant Left Main Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology, 48, 276-280.
http://dx.doi.org/10.1016/j.jacc.2006.02.067

[20]   (1994) Randomised Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383-1389.

[21]   Gan, H.L., Zhang, J.Q., Bo, P., Wang, S.X. and Lu, C.S. (2010) Statins Decrease Adverse Outcomes in Coronary Artery Bypass for Extensive Coronary Artery Disease As Well As Left Main Coronary Stenosis. Cardiovascular Therapeutics, 28, 70-79. http://dx.doi.org/10.1111/j.1755-5922.2009.00098.x

[22]   Diaz-Buschmann, I., Castro, A., Galve, E., Calero, M.J., Dalmau, R., Guzmán, R., et al. (2012) Comentarios a la Guía de Práctica Clínica de la ESC Sobre Prevención de la Enfermedad Cardiovascular (Versión 2012). Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología. Revista Española de Cardiología, 65, 869-873. http://dx.doi.org/10.1016/j.recesp.2012.08.001

[23]   Jasti, V., Ivan, E., Yalamanchili, V., Wongpraparut, N. and Leesar, M.A. (2004) Correlations between Fractional Flow Reserve and Intravascular Ultrasound in Patients with an Ambiguous Left Main Coronary Artery Stenosis. Circulation, 110, 2831-2836. http://dx.doi.org/10.1161/01.CIR.0000146338.62813.E7

[24]   Sano, K., Mintz, G.S., Carlier, S.G., de Ribamar Costa Jr, J., Qian, J., Missel, E., et al. (2007) Assessing Intermediate Left Main Coronary Lesions Using Intravascular Ultrasound. American Heart Journal, 154, 983-988.
http://dx.doi.org/10.1016/j.ahj.2007.07.001

 
 
Top